Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.
To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Gossypol
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).
Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Stein RC et al. | A preliminary clinical study of gossypol in advanced human cancer. | 1992 | Cancer Chemother. Pharmacol. | pmid:1394805 |
Jia L et al. | Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate. | 2008 | Cancer Chemother. Pharmacol. | pmid:17356822 |
Rao PN et al. | Antitumor effects of gossypol on murine tumors. | 1985 | Cancer Chemother. Pharmacol. | pmid:4006045 |
Moon DO et al. | Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells. | 2008 | Cancer Lett. | pmid:18314260 |
Tso WW | Gossypol inhibits Ehrlich ascites tumor cell proliferation. | 1984 | Cancer Lett. | pmid:6498805 |
Wei J et al. | Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists. | 2009 | Cancer Lett. | pmid:18782651 |
Hu YF et al. | Presence of antitumor activities in the milk collected from gossypol-treated dairy cows. | 1994 | Cancer Lett. | pmid:7954365 |
Shidaifat F et al. | Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta. | 1996 | Cancer Lett. | pmid:8913264 |
Ford JM et al. | Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. | 1991 | Cancer Lett. | pmid:2004358 |
Shelley MD et al. | Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. | 1999 | Cancer Lett. | pmid:10096426 |
Xin J et al. | ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo. | 2013 | Cancer Lett. | pmid:23523614 |
Kim SH et al. | Gossypol, a hyperthermic sensitizer of HeLa cells. | 1985 | Cancer Res. | pmid:4063984 |
Imai A et al. | Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. | 2012 | Cancer Res. | pmid:22158856 |
Jarvis WD et al. | Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. | 1994 | Cancer Res. | pmid:7511048 |
Jaroszewski JW et al. | Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. | 1990 | Cancer Res. | pmid:2208159 |
Quinn BA et al. | Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. | 2015 | Cancer Res. | pmid:26032425 |
Wang Y and Rao PN | Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. | 1984 | Cancer Res. | pmid:6690046 |
Tuszynski GP and Cossu G | Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. | 1984 | Cancer Res. | pmid:6581864 |
Adlakha RC et al. | Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. | 1989 | Cancer Res. | pmid:2539251 |
Wu YW et al. | An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. | 1989 | Cancer Res. | pmid:2736516 |